|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ACIPIMOX |
C10AD06 |
FR
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
NICOTINIC ACID |
C10AD02 |
FR
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
PROBUCOL |
C10AX02 |
FR
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
CIPROFIBRATE |
C10AB08 |
FR
|
II
|
05-12-2024 |
|
|
VALID
|
|
COLESTYRAMINE |
C10AC01 |
FR
|
I
|
05-12-2024 |
|
|
VALID
|
|
FENOFIBRATE |
C10AB05 |
FR
|
II
|
05-12-2024 |
FR/H/0194/002/V001/ |
13-05-2002 |
VALID
|
|
ATORVASTATIN |
C10AA05 |
FR
|
I
|
04-12-2024 |
FR/H/0558/004/ |
16-10-2015 |
VALID
|
|
ROSUVASTATIN |
C10AA07 |
FR
|
I
|
04-12-2024 |
|
11-06-2003 |
VALID
|
|
LOVASTATIN |
C10AA02 |
FR
|
I
|
03-12-2024 |
|
|
VALID
|
|
PRAVASTATIN |
C10AA03 |
FR
|
I
|
03-12-2024 |
|
|
VALID
|
|
SIMVASTATIN |
C10AA01 |
FR
|
I
|
03-12-2024 |
|
|
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
BEVACIZUMAB |
S01LA08 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
CYPROHEPTADINE |
R06AX02 |
FR
|
I
|
29-10-2024 |
None |
|
VALID
|
|
DASIGLUCAGON |
H04AA02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
FR
|
II
|
29-10-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
KETOTIFEN |
S01GX08 |
FR
|
II + Exemption
|
29-10-2024 |
FR/H/0411/001/ |
03-12-2014 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
SILVER NITRATE |
D08AL01 |
FR
|
I
|
29-10-2024 |
None |
|
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
SOTATERCEPT |
C02KC06 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005647 |
22-08-2024 |
VALID
|
|
SPARSENTAN |
C09XX01 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
TOFERSEN |
N07XX22 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
VIBEGRON |
G04BD15 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
LERCANIDIPINE |
C08CA13 |
FR
|
I
|
29-07-2024 |
|
|
VALID
|
|
EPINEPHRINE |
C01CA24 |
FR
|
I
|
26-07-2024 |
|
|
VALID
|
|
ADAGRASIB |
L01XX77 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
ETRASIMOD |
L04AE05 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|